The ORTIZ Study: Optimising RASi Therapy With SZC

Clinical trial NCT04983979 · TERMINATED

Trial details

NCT number: NCT04983979
Sponsor: Barts & The London NHS Trust
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

CKD Diabetes Mellitus, Type 2 Hyperkalemia

Start date: 2022-06-17
Primary completion: 2023-03-16
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.